NFKB1 and type 2 diabetes mellitus: In T2DM, increased IRE1α signaling activates the NF-kB pathway by phosphorylation of the c-jun N-terminal kinase 1 (JNK), well-known modulators of inflammation by promoting the expression of genes, and the activity of proteins involved in the regulation of inflammatory response.